FURTHER EXPERIENCE WITH QUINGESTANOL ACETATE AS A POSTCOITAL ORAL CONTRACEPTIVE = UNE PLUS AMPLE EXPERIENCE DE L'ACETATE DE QUINGESTANOL COMME CONTRACEPTIF ORAL POSTCOITALMISCHLER TW; BERMAN E; RUBIO B et al.1974; CONTRACEPTION; U.S.A.; DA. 1974; VOL. 9; NO 3; PP. 221-225; BIBL. 4REF.Article

ATTEMPTS TO PROGRAMME OVULATION WITH EXOGENOUS OESTROGENS AND LH-RH ANALOGUE. = TENTATIVE D'OVULATION PROGRAMMEE PAR LES OESTROGENES OU DES PRODUITS ANALOGUES A LH-RMZANARTU J; ROSNER JM; GUILOFF E et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5970; PP. 527-529; BIBL. 12 REF.Article

EFFECT OF 15(S)-15-METHYL PROSTAGLANDIN F_2ALPHA ON HUMAN OVIDUCTAL MOTILITY AND OVUM TRANSPORTCROXATTO HB; ORTIZ ME; GUILOFF E et al.1978; FERTIL. AND STERIL.; USA; DA. 1978; VOL. 30; NO 4; PP. 408-414; BIBL. 20 REF.Article

CLINICAL EVALUATION OF AN IUD WITH 200MM² OF COPPER. A NEW APPROACH IN HUMAN CONTRACEPTION = EVALUATION CLINIQUE D'UN DIU AVEC 200MM² DE CUIVRE. NOUVELLE APPROCHE DE LA CONTRACEPTIONMEDEL M; GUILOFF E; TOSCANINI C et al.1972; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1972; NO 260; PP. 47-69 (10P.); BIBL. 15 REF.Serial Issue

New insights on the mode of action of intrauterine contraceptive devices in womenALVAREZ, F; BRACHE, V; FERNANDEZ, E et al.Fertility and sterility. 1988, Vol 49, Num 5, pp 768-773, issn 0015-0282Article